Daniele Zago

Daniele Zago is COO and Chief Digital Officer at Meditrial, where he leads the R&D/IT behind Medigen Suite. With 20+ years of experience spanning eClinical software and quality management, he has led the design of FDA-compliant EDC and CTMS platforms and managed audits by Notified Bodies, Competent Authorities, and medical device manufacturers under ISO 9001, ISO 13485, and ISO 27001. He previously lectured on EU MDR 2017/745 at Università Roma Tre and writes Medigen Suite's eClinical series.

Daniele Zago is COO and Chief Digital Officer at Meditrial, where he leads the R&D/IT behind Medigen Suite. With 20+ years of experience spanning eClinical software and quality management, he has led the design of FDA-compliant EDC and CTMS platforms and managed audits by Notified Bodies, Competent Authorities, and medical device manufacturers under ISO 9001, ISO 13485, and ISO 27001. He previously lectured on EU MDR 2017/745 at Università Roma Tre and writes Medigen Suite's eClinical series.

Explore this author’s articles:

  • AI/ML18th June 20263.2 min

    Fastrial AI+: ICH E6 R3-Compliant AI for Trials

    Fastrial AI+ is the AI operating layer embedded across Medigen Suite, built for compliance with ICH E6 R3 and [...]

  • EDC18th June 20268 min

    MedDRA Coding: How Auto-Coding Saves Hours per Study

    What Is MedDRA Coding — and Why Does It Matter? MedDRA coding is the process of translating free-text [...]

  • CTMS18th June 20268.4 min

    eMVR: Electronic Monitoring Visit Reports Explained

    Too Busy to Read the Full Article? Here's What You Need to Know An eMVR is an electronic [...]

  • CTMS, EDC18th June 20268.9 min

    eClinical Software: The Case for a Unified Platform

    Choosing the right eClinical software has become a genuine competitive advantage in clinical research. Sponsors and CROs now have [...]

  • CTMS18th June 20263.9 min

    Clinical Trial Management System: Oversight to Insight

    How Maptrial CTMS+ software supports monitoring, training, and performance oversight in modern clinical studies As clinical trials increase [...]